BridgeBio Oncology (BBOT)

BridgeBio Oncology (BBOT) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• BBOT last traded at $2.31, -11.83% on the day.
• BridgeBio Oncology: P/E -0.0.
• Over the past year BBOT returned -80.65%; year to date -81.55%.

Updated 2026-11-03 12:32 UTC